IPEC Europe is the association that brings together producers, distributors and users of pharmaceutical excipients. IPEC Europe counts more than 70 member companies.
Amina is a highly effective senior leader with several years of experience in leadership, generating business growth thru technology expertise and creating value for customers utilizing business acumen.
Amina earned a Ph.D. degree in Pharmaceutical Sciences from school of Pharmacy, University de la Mediterranean France. She has over 15 years of Healthcare industry experience and have worked for several pharmaceutical and chemical companies. Amina offers an array of skills in customer-centric cultures, logical problem solving, and cross-functional collaboration, team leadership, strengthening competitive position, business development and talent acquisition.
She joined The Dow Chemical Company in Switzerland in 2011 as a Pharma application specialist to support the business growth in EMEA, and then she moved into leadership role within R&D organization. Since April 2018, Amina led the DuPont Pharma Solutions application development & innovation team, and one of her main responsibilities is to build, develop and lead high performing global team for high impact on business growth and value creation in the market, and to use her external network and strategic thinking to closely connect to the innovation needs of the healthcare industry. Since 2022, Amina is Vice-President, Global Research & Development Pharma Solutions for International Flavors & Fragrances (IFF).
For several years, Amina has been an engaged thought leader and business advocate. She is an executive board member of the International Pharmaceutical Excipients Council in Europe and a lecturer at Zurich Federal Institute of Technology (ETH). She also engages in the community high schoolers on Diversity & Inclusion that is a key asset for a business growth. Amina and her family have lived in multiple countries, experienced different cultures, languages, foods and has made priceless discoveries and memories.
Karine Roth is a senior Quality leader with more than 25 years of experiences in the pharmaceutical industry and an extensive background in Quality within Manufacturing operations, R&D, GxP Management and Regulatory Affairs.
Since June 2020, Karine is Senior Vice President Global Quality (Chief of Quality) of Ipsen Group (Boulogne Billancourt, France), previously she held different positions with increasing level of responsibility within Novartis (Basel, Switzerland) and Eli Lilly (Strasbourg, France).
Karine holds a PhD in Pharmacy from Strasbourg University.
Karsten Diehl is a biotechnologist and has been working for more than 20 years in the regulated pharmaceutical and health care environmental.
He joined BASF SE Ludwigshafen, Germany in 2011 and is part of the BASF Pharma Solutions global quality department. Karsten has experience in manufacturing pharmaceutical ingredients, contract manufacture handling, supply chain and distribution as well as general Quality- and GMP-Compliance topics.
Prior BASF SE, he has worked for Procter & Gamble within several quality position in Quality Assurance and Operational Excellence.
Kevin has been with Colorcon for over 15 years where he has been the Technical Expert in film coating, immediate release excipients and extended release excipients.
Kevin is now Regulatory Affairs and Quality Assurance Manager for Colorcon and is responsible for the EMEA region, providing regulatory support to customers in both the pharmaceutical and food industries, monitoring any regulatory changes, industry initiatives and is closely involved with the IPEC Quality and Regulatory Affairs Committee. Kevin is also responsible for Quality at the Dartford site, and hosting of all customer and certification audits as well as conducting supplier audits as an IRCA qualified Lead Auditor.
Prior to Colorcon, Kevin spent 5 years at Boots Healthcare Development, where he was Team Leader developing solid oral dosage forms for Boots Pharmacies. Kevin graduated with from Nottingham University in 1994. He has been involved in the pharmaceutical industry for 20 years.
Liz Meehan is a material scientist with a PhD from City University, London and more than 30 years experience in material characterisation.
She has worked in the pharmaceutical industry for 10 years, in the Pharmaceutical Development department of AstraZeneca, specialising in the field of excipient characterisation, relating excipient properties to functionality in dosage form design. More generally her activities include excipient risk assessment/mitigation for the development of robust pharmaceutical formulations.
Dr. Frank Milek is an industrial pharmacist and has been working in pharmaceutical excipients industry for more than 15 years, specialised in the field of supply chain and distribution. He is registered QP according to EU regulation and responsible at Aug. Hedinger GmbH & Co. KG for Quality, Regulatory Affairs and GMP.
Frank is an active member of the EXCiPACT project.
Dr. Mahmud Yunis has been working for 13 years at BIOGRUND in several positions.
In his current function as Technical Director, he is responsible for preparing and implementing global strategic regulatory plan for BIOGRUND products and the strategic development of the Quality, Production and R&D department. He has a PhD degree in Analytical Chemistry from University of Muenster, Germany. Before joining BIOGRUND he worked for a consulting company on the area of GxP procedures and processes for five years.